Diagnostics AI
By
95 Pathologists, 11 Hospitals, 1 AI Platform: Can PathAI and Northwestern Medicine Set the Standard for AI-Driven Pathology?
Key Takeaways• 95 pathologists across 11 hospitals to adopt PathAI’s AISight® digital pathology platform, enabling real-time, AI-enhanced diagnostics•…
25 AI-Driven Companies Leading, Top the 2025 Transformation: Are MedTech Giants Like Regeneron, PHC Holdings, and Henry Schein Redefining Global Healthcare?
Key Highlights AI-First Innovation Is No Longer Optional—It’s the Industry Standard The 2025 MedTech leaderboard showcases how artificial…
How AccurKardia’s Award-Winning AccurECG™ Platform Redefine ECG Diagnostics with AI?
Key Highlights: A Landmark Recognition for a Game-Changing ECG Technology AccurKardia’s AccurECG™ has been named the “Best New…
Can Clairity’s FDA-Approved AI Breast Cancer Prediction Tool Transform How We Predict Breast Cancer Risk Over 5 Years?
Key Highlights: AI-Driven Risk Prediction: A Breakthrough in Preventive OncologyBoston-based Clairity received FDA de novo authorization for Clairity…
Can VUMC’s New AI Technologies Reshape Cancer Diagnostics and Immunotherapy for Millions?
Key Highlights AI-Powered MSI-SEER Revolutionizes Tumor ProfilingVanderbilt University Medical Center (VUMC), in collaboration with Mayo Clinic and leading…
Can Bayer’s Partnership with Altis Labs’ AI Boost Lung Cancer Trial Accuracy by 50%? ASCO 2025 Reveals Game-Changing Results
Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…
